Intco Medical Technology Co., Ltd.

SZSE:300677 주식 보고서

시가총액: CN¥16.5b

Intco Medical Technology 미래 성장

Future 기준 확인 4/6

Intco Medical Technology (는) 각각 연간 34.1% 및 17.1% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 34.2% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 9.2% 로 예상됩니다.

주요 정보

34.1%

수익 성장률

34.2%

EPS 성장률

Medical Equipment 수익 성장26.5%
매출 성장률17.1%
향후 자기자본 수익률9.2%
애널리스트 커버리지

Low

마지막 업데이트30 Aug 2024

최근 미래 성장 업데이트

Recent updates

Intco Medical Technology (SZSE:300677) Seems To Use Debt Quite Sensibly

Nov 25
Intco Medical Technology (SZSE:300677) Seems To Use Debt Quite Sensibly

There May Be Underlying Issues With The Quality Of Intco Medical Technology's (SZSE:300677) Earnings

Nov 04
There May Be Underlying Issues With The Quality Of Intco Medical Technology's (SZSE:300677) Earnings

Intco Medical Technology (SZSE:300677) Seems To Use Debt Quite Sensibly

Aug 19
Intco Medical Technology (SZSE:300677) Seems To Use Debt Quite Sensibly

Intco Medical Technology Co., Ltd. (SZSE:300677) Looks Inexpensive But Perhaps Not Attractive Enough

Jul 15
Intco Medical Technology Co., Ltd. (SZSE:300677) Looks Inexpensive But Perhaps Not Attractive Enough

Capital Allocation Trends At Intco Medical Technology (SZSE:300677) Aren't Ideal

May 21
Capital Allocation Trends At Intco Medical Technology (SZSE:300677) Aren't Ideal

Intco Medical Technology (SZSE:300677) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

May 02
Intco Medical Technology (SZSE:300677) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Intco Medical Technology Co., Ltd.'s (SZSE:300677) Business Is Trailing The Market But Its Shares Aren't

Mar 28
Intco Medical Technology Co., Ltd.'s (SZSE:300677) Business Is Trailing The Market But Its Shares Aren't

수익 및 매출 성장 예측

SZSE:300677 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (CNY Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/202612,9231,912N/A2,1441
12/31/202510,5521,531N/A1,7041
12/31/20249,0321,215N/A1,3531
9/30/20248,975740-1,110776N/A
6/30/20248,136677-763723N/A
3/31/20247,549774-532839N/A
12/31/20236,919383-936502N/A
9/30/20236,444321-629-3N/A
6/30/20236,168520-504352N/A
3/31/20235,899393-865474N/A
1/1/20236,614629-6501,065N/A
9/30/20227,8061,126-7181,688N/A
6/30/20229,3061,954-4062,766N/A
3/31/202211,7933,7781,7436,021N/A
1/1/202216,2407,4303,2368,680N/A
9/30/202118,5389,5775,40711,705N/A
6/30/202120,06110,9656,93012,690N/A
3/31/202119,79810,6146,81011,390N/A
12/31/202013,8377,0075,6908,590N/A
9/30/20209,5034,4253,6985,388N/A
6/30/20205,5482,0291,6962,781N/A
3/31/20202,362274-46543N/A
12/31/20192,083178-207330N/A
9/30/20192,042176-212204N/A
6/30/20192,003181-73251N/A
3/31/20191,963191-132200N/A
12/31/20181,893179-123186N/A
9/30/20181,818162-155193N/A
6/30/20181,764153N/A213N/A
3/31/20181,776147N/A282N/A
12/31/20171,750145N/A248N/A
9/30/20171,639134N/A155N/A
6/30/20171,50197N/A96N/A
3/31/20171,31484N/A67N/A
12/31/20161,18386N/A81N/A
12/31/201599864N/A76N/A
12/31/201488532N/A77N/A
12/31/201371311N/A75N/A

애널리스트 미래 성장 예측

수입 대 저축률: 300677 의 연간 예상 수익 증가율( 34.1% )이 saving rate( 2.8% 보다 높습니다. ).

수익 vs 시장: 300677 의 연간 수익( 34.1% ) CN 시장( 26.3% 보다 빠르게 성장할 것으로 예상됩니다. 26.3% 연간).

고성장 수익: 300677 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: 300677 의 수익(연간 17.1% ) CN 시장( 13.9% 보다 빠르게 성장할 것으로 예상됩니다. 13.9% 연간).

고성장 수익: 300677 의 수익(연간 17.1% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: 300677 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 9.2 %).


성장 기업 발견